<DOC>
	<DOCNO>NCT01095328</DOCNO>
	<brief_summary>Q fever Netherlands become common . A Q fever infection serious threat certain risk group , include pregnant woman . Pregnant woman often general population asymptomatic . Studies France show infection Coxiella burnetii may cause obstetric complication include spontaneous abortion , intrauterine fetal death , intrauterine growth retardation oligohydramnios . The aim study ass effectiveness cost effectiveness multidisciplinary screening program , whereby pregnant woman first line healthcare high-risk area Q fever screen single blood sample pregnancy . If find positive Q fever , advise antibiotic treatment follow part regular healthcare . Treatment therefore part study protocol . The result study give insight risk asymptomatic Q fever pregnancy benefit harm screen strategy pregnancy . This study use give evidence base advice Dutch minister health screen Q fever pregnancy .</brief_summary>
	<brief_title>A Screening Strategy Q Fever Among Pregnant Women</brief_title>
	<detailed_description>We conduct cluster randomize control trial among pregnant woman within area high transmission . The study participant recruit midwife high risk area , define postal code RIVM . To inform public area study publish article local newspaper . The midwife center randomize recruit pregnant woman either control group intervention group . The pregnant woman receive study information mail use midwife patient file . It estimate approximately 10,000 eligible woman live area transmission . After write informed consent , start strategy midwife center randomize . Participants ask blood sample second trimester pregnancy , possibly combine routine structural ultrasound around 20 week pregnancy minimize hospital visit . If participant enrol third trimester , blood sample soon possible inclusion . When take part intervention group sample test immediately Q fever . If find positive acute chronic Q fever , patient refer , accord local protocol , hospital pregnancy monitor long-term bacteriostatic treatment . Follow-up blood sample require 14 day , 3 , 6 12 month first blood sample part standardize control Q fever disease diagnose possible chronicity infection . Furthermore , current routine pregnant woman treat antibiotic Q fever perform monthly blood analysis monitor treatment , serological parameter descend , control bring back every two month . According local protocol patient Q fever deliver hospital . After pregnancy serology continue check-ups 3 , 6 12 month follow current protocol . Furthermore , delivery bacteriocide treatment doxycycline alternative start specialist part regular health care . In control arm blood sample store , analyze Q fever delivery . If test positive Q fever pregnancy antibiotic could start needed part regular health care . At baseline , questionnaire administer participant ask current pregnancy , pregnancy outcome previous pregnancy demographic . Further risk factor pregnancy outcome also obtain smoke drinking behavior , risk-elevating comorbidities medication use . After delivery relevant outcome data collect questionnaire fill midwife , GP specialist delivery , notably presence obstetric complication . One month delivery end pregnancy , last questionnaire administer participant verify potential long-term consequence Q fever , potential loss income , health-related quality-of-life , fatigue depressive symptom . Furthermore question ask condition newborn risk-accessing question Q fever infection ask . In context secondary research question extra blood sample require , placenta well amniotic fluid collect delivery . The latter take place limit number woman give birth hospital . All participant receive usual care ask visit general practitioner symptom Q fever occur . He/she start diagnostic research treatment refer patient hospital . Furthermore , arm access expert team support .</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Q Fever</mesh_term>
	<criteria>pregnant first line healthcare eighteen year older sign informed consent form estimate date delivery June 1th 2010 en December 31th 2010 unable fulfill study procedure absence inform consent test positive Q fever prior pregnancy unable understand Dutch</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Q fever</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Screening</keyword>
	<keyword>Cost-effectiveness</keyword>
</DOC>